Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - TOTAL EQUITY
Total Equity OCUL - Ocular Therapeutix, Inc.
91.1 M
LAST VALUE
1.76%
2 YEAR CAGR
20.50%
5 YEAR CAGR
13.45%
10 YEAR CAGR